Article
Standardized and simplified reporting of next-generation sequencing results in advanced non-small-cell lung cancer: Practical indications from an Italian multidisciplinary group.
Critical reviews in oncology/hematology - 1 Jan 2024
Malapelle Umberto, Donne Alessandro Delle, Pagni Fabio, Fraggetta Filippo, Rocco Elena Guerini, Pasello Giulia, Perrone Giuseppe, Pepe Francesco, Vatrano Simona, Pignata Sandro, Pinto Carmine, Pruneri Giancarlo, Russo Antonio, Soto Parra Hector J, Vallone Stefania, Marchetti Antonio, Troncone Giancarlo, Novello Silvia
Abstract excerpt
Molecular biomarker testing is increasingly becoming standard of care for advanced non-small cell lung cancer (NSCLC). Tissue and liquid biopsy-based next-generation sequencing (NGS) is now highly recommended and has become an integral part of the routine management of advanced NSCLC patients. This highly sensitive approach can simultaneously and efficiently detect multiple biomarkers even in scant samples....
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.